Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alican
Istanbul, Turkeyalican.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Alican is a pet health biotechnology company that specializes in the development of non-invasive diagnostic and monitoring solutions for companion animals. The company's primary focus is on the early detection and management of chronic conditions such as kidney disease and diabetes in cats and dogs through smart monitoring technology. By integrating advanced biosensors with data analytics, Alican provides pet owners and veterinarians with real-time health insights to improve clinical outcomes. Their product suite includes smart litter and diagnostic tools designed to simplify the monitoring of metabolic and physiological markers.
- Therapeutic areas
- EndocrinologyNephrology
- Modalities
- DeviceDiagnosticSmall molecule
- Industry
- Veterinary
Beyond the preview
Go deeper on Alican.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alican.